Drug design of structure-assisted and mechanism-based is a newer strategy of drug design, and can open up a new method for glycobiology.

• 结构辅助并基于机理进行有目的药物设计,仍是当前药物设计的主流,它可以为糖生物学开辟一个新的领域。